Published date: 10 October 2019

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 19 August 2019

Contract summary

Industry

  • Pharmaceutical products - 33600000

Location of contract

Any region, Scotland, Wales, Northern Ireland

Value of contract

£0

Procurement reference

tender_195762/803907

Published date

10 October 2019

Closing date

19 August 2019

Contract start date

1 April 2020

Contract end date

31 March 2022

Contract type

Supply contract

Procedure type

Restricted procedure (above threshold)

A two-stage procedure, where the first stage is used to select suppliers, who are then invited to bid in the second stage.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

Framework Agreement has been established for the supply of pralidoxime chloride for injection, to place call-offorders as and when required during the life of the Framework Agreement.
The duration of the Framework Agreement is 2 years with an option to extend for up to an additional 2 years.

More information

Previous notice about this procurement

Framework Agreement for the supply of pralidoxime chloride injection

  • Opportunity
  • Published 12 September 2019, last edited 12 September 2019

Attachments

Award information

Awarded date

2 October 2019

Contract start date

1 April 2020

Contract end date

31 March 2022

Total value of contract

£0

This contract was awarded to 1 supplier.

Baxter Healthcare Ltd

Address

Caxton Way, Thetford, Norfolk, IP24 3SE

Reference

Companies House number: 461365

Supplier is SME?

No

Supplier is VCSE?

No

About the buyer

Address

2nd Floor, Rutland House
Runcorn
LL12 0DX
England

Email

lynne.nichols@dhsc.gov.uk